Analgesic effect of oral ketamine in chronic neuropathic pain of spinal origin: A case report

被引:35
作者
Fisher, K
Hagen, NA
机构
[1] Univ Calgary, Clin Neurosci, Calgary, AB, Canada
[2] Univ Calgary, Dept Oncol, Calgary, AB, Canada
[3] Tom Baker Canc Clin, Dept Med, Calgary, AB, Canada
关键词
ketamine; N-methyl-D-aspartate receptor; pain management; neuropathic pain; oral administration;
D O I
10.1016/S0885-3924(99)00018-4
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Ketamine is an injectable anesthetic induction agent that has been reported to have analgesic activity in pain from a variety of mechanisms, but predominantly in neuralgic and dysesthetic neuropathic pain. In this case report we illustrate the effectiveness of ketamine in a patient with neuropathic pain resulting from cauda equina trauma. Among the issues addressed are the role of pretreatment with haloperidol to prevent ketamine-induced psychomimetic effects, the potential for fewer side effects and a need for lower doses when ketamine is administered orally, and the need for further study regarding appropriate monitoring parameters during the titration phase. Oral ketamine can be effective in treatment refractory chronic neuropathic pain of spinal origin. J Pain Symptom Manage 1999;18:61-66. (C) U.S. Cancer Pain Relief Committee, 1999.
引用
收藏
页码:61 / 66
页数:6
相关论文
共 47 条
[1]  
BAKONJA M, 1994, PAIN, V56, P51
[2]   ON THE MECHANISM OF THE INTERACTION OF KETAMINE AND HALOTHANE INVITRO [J].
BANSINATH, M ;
WARNER, W ;
TANG, CK ;
TURNDORF, H ;
PUIG, MM .
GENERAL PHARMACOLOGY, 1992, 23 (06) :1183-1187
[3]   ALTERATIONS IN RESPONSE TO SOMATIC PAIN ASSOCIATED WITH ANAESTHESIA .20. KETAMINE [J].
BOVILL, JG ;
DUNDEE, JW .
BRITISH JOURNAL OF ANAESTHESIA, 1971, 43 (05) :496-&
[4]   Ketamine injection used orally [J].
Broadley, KE ;
Kurowska, A ;
Tookman, A .
PALLIATIVE MEDICINE, 1996, 10 (03) :247-250
[5]   Amitriptyline - A review of its pharmacological properties and therapeutic use in chronic pain states [J].
Bryson, HM ;
Wilde, MI .
DRUGS & AGING, 1996, 8 (06) :459-476
[6]   EFFECTIVE TREATMENT OF SEVERE CANCER PAIN OF THE HEAD USING LOW-DOSE KETAMINE IN AN OPIOID-TOLERANT PATIENT [J].
CLARK, JL ;
KALAN, GE .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1995, 10 (04) :310-314
[7]   INHIBITION BY KETAMINE OF MUSCARINIC ACETYLCHOLINE-RECEPTOR FUNCTION [J].
DURIEUX, ME .
ANESTHESIA AND ANALGESIA, 1995, 81 (01) :57-62
[8]   Norketamine, the main metabolite of ketamine, is a non-competitive NMDA receptor antagonist in the rat cortex and spinal cord [J].
Ebert, B ;
Mikkelsen, S ;
Thorkildsen, C ;
Borgbjerg, FM .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 333 (01) :99-104
[9]   CONTINUOUS SUBCUTANEOUS ADMINISTRATION OF THE N-METHYL-D-ASPARTIC ACID (NMDA) RECEPTOR ANTAGONIST KETAMINE IN THE TREATMENT OF POSTHERPETIC NEURALGIA [J].
EIDE, PK ;
STUBHAUG, A ;
OYE, I ;
BREIVIK, H .
PAIN, 1995, 61 (02) :221-228
[10]   Relief of glossopharyngeal neuralgia by ketamine-induced N-methyl-aspartate receptor blockade [J].
Eide, PK ;
Stubhaug, A .
NEUROSURGERY, 1997, 41 (02) :505-508